CDX2 and pancreatic intraductal papillary-mucinous neoplasm: Meanwhile, CDX2 (+)/p-CK (+)/CK19 (+)/P53 (20%)/Ki67 (15–30%) further showed progress with atypical grade and invasive phenotype of the APD-IPMN.